Targets, Modulators, and Delivery Program
This program is developing and delivering small molecules to modulate validated cancer targets as eventual cancer therapeutics.
The program brings together investigators with complementary expertise to facilitate translation of basic science discoveries across the bench-to-bedside continuum within the research programs of the Eppley Institute and its partner, the Fred & Pamela Buffett Cancer Center.
Areas of expertise include:
- Cancer target validation and characterization
- Medicinal chemistry
- Pharmacology
- Nanodelivery
The program has led efforts to establish several shared resources, including the Synthetic and Medicinal Chemistry Resource, the Computational Chemistry Resource, and the Translational Drug Development Resource.
Interim Program Leader
Hartmann Chair, Department of Biochemistry and Molecular Biology
Professor and Chairman, Department of Biochemistry and Molecular Biology
Associate Director, Translational Research, Fred & Pamela Buffett Cancer Center
Program Members
Professor, UNMC Department of Neurosurgery
Director, Brain and Spine Cancer Center, Nebraska Medicine
Associate Professor, UNMC Department of Radiation Oncology
Clinic Medical Director, Nebraska Medicine
Associate Professor, UNMC Division of Hematology and Oncology
Chief, UNMC Division of Hematology and Oncology
Deputy Director, Fred and Pamela Buffett Cancer Center
Professor, UNMC Eppley Institute for Research in Cancer and Allied Diseases
Professor, UNMC Department of Internal Medicine
Research focus: Genitourinary Oncology
Associate Professor, UNMC Department of Pharmaceutical Sciences
402-559-9361
402-559-5673
Member Directory
Find the complete list of Target, Modulators, and Delivery program members in the Member Directory, and learn about their research focus, tools, and techniques that support team science.